您当前的位置：
首页 >
文章列表页 >
Clinical observation of everolimus combined with letrozole and conventional chemotherapy for metastatic/recurrent endometrial carcinoma
更新时间：2026-02-10

    • Clinical observation of everolimus combined with letrozole and conventional chemotherapy for metastatic/recurrent endometrial carcinoma

    • “Experts from Nanyang Central Hospital have found that the combination of everolimus and letrozole with conventional chemotherapy can significantly improve the short-term efficacy and prolong the survival of patients with metastatic/recurrent endometrial cancer, but attention should be paid to toxic side effects.”
    • ZHONGGUO YAOFANG   Vol. 37, Issue 1, Pages: 61-65(2026)

    • DOI：10.6039/j.issn.1001-0408.2026.01.11    

      CLC： R711.74;R969.4

    • Received：20 August 2025，

      Revised：2025-11-20，

      Accepted：02 December 2025，

      Published：15 January 2026

    移动端阅览

  • BAI Dongyan,WU Yu,ZHANG Shu,et al.Clinical observation of everolimus combined with letrozole and conventional chemotherapy for metastatic/recurrent endometrial carcinoma[J].ZHONGGUO YAOFANG,2026,37(01):61-65. DOI： 10.6039/j.issn.1001-0408.2026.01.11.

  •  
  •  

0

Views

13

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

No data

Related Author

No data

Related Institution

No data
0